Dr. Anita Gupta, a WEF Member Expert and 2024 World Women Davos Agenda Delegate, is a pioneering physician-pharmacist renowned for her innovative solutions to critical health challenges. Previously serving as Senior Advisor at the Milken Institute Center for Public Health and NYC's Chief Surgeon, she leads impactful initiatives on the global drug crisis and medicine access. Appointed by the American Society of Anesthesiologists, Dr. Gupta advocates for expanding naloxone access at the US FDA and addresses the drug crisis with frontline insights. Her expertise on synthetic opioids and drug trade, early warning systems is internationally recognized. Dr. Gupta also contributes to the WEF Global Member Experts on Biotechnology, Pandemic Preparedness, and Future of Health, as well as the National Academies of Medicine Cancer Policy Forum and Global Innovation Forum. Her leadership spans top governmental, academic, and industry institutions, including the US FDA, National Quality Forum, Department of Defense, Gates Foundation’s Innovation Equity Forum, Princeton Asian American Alumni Association, and Harvard’s Alum for Women. Honored by the New York Times, Washington Post, Forbes, and WebMD’s 'Pain Expert Blog,' Dr. Gupta is celebrated as one of the most influential healthcare experts globally, earning accolades like the Top 10 Fierce Healthcare Women of Influence and recognition as a Top 100 Most Inspiring Leader and Top 10 Global Emerging Leader. She is also a recipient of the National Academies Patient Advocacy Award and a Goldman Sachs 10K Small Business Scholar. As a leading force in healthcare transformation, Dr. Gupta exemplifies the World Economic Forum’s dedication to equitable healthcare access.